Product Datasheet  
JAK2(Phospho-Y1007+Y1008) Antibody  
Catalog Number: 13352  
Technical:tech@swbio.com  
Information:info@swbio.com  
Description  
  • host_species：  
  • Amount：  
  • 100μgμg
  • Swiss-Prot No.：  
  • Swiss-Prot#:O60674
  • Form of Antibody：  
  • 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
  • Storage：  
  • Store at -20˚C
  • Immunogen：  
  • Synthetic phospho-peptide corresponding to residues surrounding Tyr1007 and 1008 of human JAK2.
  • reactivity：  
  • Hu, Ms, Rt
  • appl_detail：  

  • WB: 1:500-1:1,000
    IHC: 1:50-1:200
    ICC: 1:50-1:200

  • other_names：  
  • JAK 2 antibody
    JAK-2 antibody
    JAK2 antibody
    JAK2_HUMAN antibody
    Janus Activating Kinase 2 antibody
    Janus kinase 2 (a protein tyrosine kinase) antibody
    Janus kinase 2 antibody
    JTK 10 antibody
    JTK10 an
  • Purification：  
  • ProA affinity purified
  • Specificity：  
  • Applications：  
  • WB, ICC, IHC, IP
  • Background：  

  • JAK2 (Janus Kinase 2) belongs to the emerging family of non-receptor Janus tyrosine kinases, which regulate a spectrum of cellular functions downstream of activated cytokine receptors in the lympho-hematopoietic system. Immuno-logical stimuli, such as interferons and cytokines, induce recruitment of Stat transcription factors to cytokine receptor-associated JAK2. JAK2 then phosphorylates proximal Stat factors, which subsequently dimerize, translocate to the nucleus and bind to cis elements upstream of target gene promoters to regulate transcription. The canonical JAK-Stat pathway is integral to maintaining a normal immune system by stimulating proliferation, differentiation, survival, and host resistance to pathogens. Altering JAK-Stat signaling to reduce cytokine induced pro-inflammatory responses represents an attractive target for anti-inflammatory therapies. Within the JAK2 kinase domain, there is a region that has considerable sequence homology to the regulatory region of the insulin receptor. Among a variety of sites, Tyrosines 1007 and 1008 are sites of trans- or autophosphorylation in vivo and in in vitro kinase reactions.




 
© Signalway Biotechnology All Rights Reserved.